[ad_1]
The "central account", the official always draws right.
The Comptroller General's Department revised criteria for the direct disbursement of medical expenses for patients with cancer and hematology. I hope that patients use the right medicine. Some medicines can be deadly. And give more access to medicine. The use of outpatient drugs and disbursement directly before February 14, 61 also paid the exact same thing. Except for new patients Try to pay first.
Miss Suttirat Ratanachote, Director General, Department of the Comptroller General Revealed that the Ministry has established the criteria. And the direct disbursement of medical expenses. For cancer and hematologic patients (OCPA), which require expensive drugs. Determine the criteria Make the use of the drug reasonable, cost-effective and safe for patients. Because of the drugs. Suitable for the specific treatment of certain diseases. Only a few cases And a dangerous drug. May cause a life-threatening illness.
. And the conditions for the disbursement of cancer drugs. The cost is high. Has been implemented by a working group. It consists of medical professionals from relevant professional organizations such as the Thailand Oncology Association The task force should also prohibit the disbursement of expensive drugs using other drugs. Or alternative treatment. And have similar results. Patient Rights Wellness Officer Continue to receive quality medical care. However, to reduce the impact of the measures. This is a list of drugs that continue to shell out. In case of outpatient medical treatment The right to pay before. Then bring the receipt to the company. Apply only to new patients. For patients taking medications and withdrawing directly before February 14, 61, they still paid directly.
Miss Suttirat said this improvement. The drug was added to the system from the original drug with nine to nine items, and increased the conditions and indications for the drug from seven diseases to 17 diseases. Cancer patients are 1.5 times more likely to be treated for lung cancer and twice as likely for breast cancer, such as breast cancer. (Trastuzumab), only to propagate the spread. It will expand both the propagation and the startup phase. Gefitinib will be available only in parallel to the third treatment, it will also be available from the first treatment.
In addition, the six OCPA regimens are listed in the National Drug Account Booklet (2). Only the OCPA disbursement indicator is defined. This makes it more accessible to patients. "The Ministry has revised this rule.Consider the reasonableness of the drug.Compatible with the medical evolution Be safe with admitted patients.Patients' rights Continued access to generic drugs outside the national registry medications If necessary, medical (F, b, e, v, n, t, s)
{if (f.fbq) returns; n = f.fbq = function () {n.callMethod?
n.callMethod.apply (n, arguments): n.queue.push (arguments)};
f._fbq = n; n.push = n; nedload =! 0; n.version = 2.0 & # 39 ;;
n.queue = []; t = b.createElement (e); t.async = 0;
t.src = v; s = b.getElementsByTagName (e) [0];
s.parentNode.insertBefore (t, s)} (window, document, & quot; script & # 39;
& # 39; https: //connect.facebook.net/en_US/fbevents.js');
fbq (& # 39 ;, & # 39; 655602084608708 & # 39;);
fbq ("track", "Pageview");
fbq ('track', 'ViewContent', 'content_name': 'content_name': 'content_type', & # 39; ; content_type: & # 39; content_type & quot; Function (d, s, id)
var js, fjs = d.getElementsByTagName (s) [0];
if (d.getElementById (id)) returns;
js = d.createElement (s); js.id = id;
js.src = "http://connect.facebook.net/en_US/sdk.js";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
// Init. Javascript SDK
window.fbAsyncInit = function () {
FB.init ({
appId: & # 39; 546617158831626 & # 39;
cookie: true, // enable cookies to allow the server to access the session
xfbml: true, // parse social plugins on this page
phiên bản: & # 39; v2.10 & # 39; // hãy sử dụng đồ họa graphic api 2.8
}
}
[ad_2]
Source link
